S TOCKHOLM − U.S. scientists Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in Medicine for the discovery of microRNA ...

Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease.

From a pharmaceutical strategy perspective, the findings elevate miR‑155 as a tissue‑level biomarker and potential target for ...

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy.

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Gary Ruvkun is used to getting awards — but for him, the Nobel Prize ...

Two American scientists were jointly awarded the Nobel Prize for m edicine or p hysiology Monday for their ground-breaking work on how genes behave. Victor Ambros and Gary Ruvkun discovered microRNA, ...

MicroRNAs can make plants more capable of withstanding drought, salinity, pathogens and more. However, in a recent study scientists showed just how much we didn't know about the intricate processes ...

Before SARS-CoV-2 and COVID-19, there was the Zika virus epidemic, lasting from 2015 to 2016. The Zika virus can cause serious birth defects and abnormalities. During the epidemic, one of the most ...

MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality, according to study results published online ahead of print in the ...